Last reviewed · How we verify
NCT05923398
Digital Interventions to Understand and Mitigate Stress Response
NA trial testing Digital Intervention Group in Distress, Emotional in 100 participants. Completed in 8 December 2023.
8 December 2023
Quick facts
| Lead sponsor | Unity Health Toronto |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 100 |
| Start date | 1 May 2023 |
| Primary completion | 8 December 2023 |
| Estimated completion | 8 December 2023 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- Digital Intervention Group
Conditions studied
- Distress, Emotional — all drugs for Distress, Emotional →
- Stress Response Among Nursing Professionals During the COVID-19 — all drugs for Stress Response Among Nursing Professionals During the COVID-19 →
- Stress Reaction; Acute — all drugs for Stress Reaction; Acute →
Sponsor
Unity Health Toronto — full company profile →
Who can join
18 and older, any sex, with Distress, Emotional or Stress Response Among Nursing Professionals During the COVID-19. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Stress, anxiety, distress, and burnout are exceptionally high among healthcare workers at the frontline of the COVID-19 pandemic. The understanding of factors underlying distress and resilience in complex workplace contexts is limited, and there are limited evidence-based interventions for stress and moral distress among frontline healthcare workers. The purpose of this study is to use a Digital Intervention Suite (a combination of Virtual Reality \[VR\], a web-based platform, and a wearable \[Oura Ring\]) to understand and reduce the experience of stress/distress faced by nursing professionals.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Digital Interventions to Understand and Mitigate Stress Response: Protocol for Process and Content Evaluation of a Cohort Study.
Martin J, Rueda A, Lee GH, Tassone VK, et al · · 2024 · cited 3× · PMID 38709554 · DOI 10.2196/54180
Verify or expand the search:
- PubMed search for NCT05923398
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Distress, Emotional
Currently open trials in the same condition.
- NCT07478393 — Readiness and Progress in Emotion Regulation Therapy · NA · recruiting
- NCT06099743 — ASCENT Intervention for Brain Tumor Patients · NA · recruiting
- NCT07209306 — WHO Psychological Interventions for Mental Health Outcomes in Migrants Resettled in Italy: the ADVANCE Trial · NA · recruiting
- NCT06881342 — Evaluating the Feasibility of a School-based Stepped Care Program for Internalizing Symptoms in Adolescents in Pakistan · NA · active not recruiting
- NCT06888141 — Stress Management for College Students · NA · recruiting
Other Unity Health Toronto trials
Trials by the same sponsor.
- NCT07507409 — Innovative Sternal Closure Techniques: Evaluating STRATAFIX™ and DERMABOND™ for Reduced Complications in CABG Patients · Phase 4 · not yet recruiting
- NCT07455487 — First Appendectomy Using Revolve Surgical Robotic Arm · NA · not yet recruiting
- NCT07301632 — Ecstasy to Alleviate SEvere Chronic Neuropathic Pain Trial · Phase 2 · recruiting
- NCT07314905 — Adaptive Platform Trial of Treatments for Respiratory Infections in Community Settings (TreatResp) · Phase 3 · not yet recruiting
- NCT06571916 — Brief Skills for Safer Living (Brief-SfSL) · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05923398 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Unity Health Toronto
- Last refreshed: 14 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05923398.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing